W. Wolfgang Fleischhacker mainly focuses on Psychiatry, Schizophrenia, Internal medicine, Antipsychotic and Psychosis. His studies in Psychiatry integrate themes in fields like Adverse effect, Randomized controlled trial and Clinical psychology. He has included themes like Psychosocial, Quality of life, Pediatrics and Compliance in his Schizophrenia study.
The concepts of his Internal medicine study are interwoven with issues in Anesthesia, Endocrinology, Clozapine and Atypical antipsychotic. The Antipsychotic study combines topics in areas such as Clinical trial, Health care and Cohort study. W. Wolfgang Fleischhacker has included themes like Sexual intercourse, Significant difference and Risk factor in his Psychosis study.
His main research concerns Psychiatry, Schizophrenia, Internal medicine, Antipsychotic and Clozapine. His Psychiatry research is multidisciplinary, incorporating perspectives in Clinical trial and Clinical psychology. He interconnects Bipolar disorder and Cognition in the investigation of issues within Clinical psychology.
His research integrates issues of Psychosocial, Psychosis and Psychopathology in his study of Schizophrenia. His studies deal with areas such as Gastroenterology, Placebo, Endocrinology and Atypical antipsychotic as well as Internal medicine. His studies in Antipsychotic integrate themes in fields like Adverse effect and Olanzapine.
His scientific interests lie mostly in Psychiatry, Schizophrenia, Antipsychotic, Internal medicine and Clinical psychology. W. Wolfgang Fleischhacker has researched Psychiatry in several fields, including Placebo and Clinical trial. His Schizophrenia research integrates issues from Psychosocial, Psychosis, Pediatrics and Double blind.
Within one scientific family, he focuses on topics pertaining to Olanzapine under Antipsychotic, and may sometimes address concerns connected to Quetiapine, Schizoaffective disorder, Risperidone and Clozapine. His Internal medicine study combines topics from a wide range of disciplines, such as Paliperidone Palmitate, Akathisia and Positive and Negative Syndrome Scale. His Clinical psychology research includes elements of Psychological intervention, Bipolar disorder and Mental illness.
His primary areas of study are Psychiatry, Schizophrenia, Antipsychotic, Clinical psychology and Randomized controlled trial. His Psychiatry study combines topics in areas such as Clinical trial and Pediatrics. His Schizophrenia research is multidisciplinary, relying on both Discontinuation, Young adult, Bipolar disorder, Depression and Cognition.
W. Wolfgang Fleischhacker combines subjects such as Internal medicine, Psychosis and Clozapine with his study of Antipsychotic. His Psychosis study integrates concerns from other disciplines, such as Neuropsychology and Intensive care medicine. His study in Clinical psychology is interdisciplinary in nature, drawing from both Psychosocial, Facial expression and Positive and Negative Syndrome Scale.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
S. Miyamoto;N. Miyake;Lars Jarskog;W. W. Fleischhacker.
Molecular Psychiatry (2012)
Guidelines for depot antipsychotic treatment in schizophrenia
John M.John Kane;Eugenio Aguglia;A. CarloA. Altamura;José Luis Ayuso Gutierrez.
European Neuropsychopharmacology (1998)
Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges.
W Wolfgang Fleischhacker;Marcelo Cetkovich-Bakmas;Marc De Hert;Charles H Hennekens.
The Journal of Clinical Psychiatry (2008)
Comparison of acamprosate and placebo in long-term treatment of alcohol dependence.
A.B Whitworth;H Oberbauer;W.W Fleischhacker;O.M Lesch.
The Lancet (1996)
Sex differences in cognitive functions
Elisabeth M. Weiss;Georg Kemmler;Eberhard A. Deisenhammer;W.Wolfgang Fleischhacker.
Personality and Individual Differences (2003)
Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic.
W Wolfgang Fleischhacker;Mariëlle Eerdekens;Keith Karcher;Gary Remington.
The Journal of Clinical Psychiatry (2003)
Metabolic side effects of antipsychotic medication.
A. Tschoner;J. Engl;M. Laimer;S. Kaser.
International Journal of Clinical Practice (2007)
Quality of life in breast cancer patients--not enough attention for long-term survivors?
Bernhard Holzner;Georg Kemmler;Martin Kopp;Roland Moschen.
Compliance with antipsychotic drug treatment: influence of side effects
Fleischhacker Ww;Meise U;Günther;Kurz M.
Acta Psychiatrica Scandinavica (1994)
Sex differences in brain activation pattern during a visuospatial cognitive task: a functional magnetic resonance imaging study in healthy volunteers.
E. Weiss;C.M. Siedentopf;A. Hofer;E.A. Deisenhammer.
Neuroscience Letters (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: